pyridoxamine has been researched along with levuglandin e2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amarnath, V; Boutaud, O; Brantley, EJ; Davies, SS; Hudson, BG; Oates, JA; Roberts, LJ; Voziyan, PA; Zagol-Ikapitte, I | 1 |
| Alam, DA; Amarnath, V; Bernoud-Hubac, N; Davies, SS; Guichardant, M; Lagarde, M; Lefils, J; Roberts, LJ | 1 |
2 other study(ies) available for pyridoxamine and levuglandin e2
| Article | Year |
|---|---|
Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.
Topics: Aldehydes; Animals; Arachidonic Acids; Catalysis; Cell Line, Tumor; Free Radical Scavengers; Humans; Hydrogen Peroxide; Isoprostanes; Lipids; Ovalbumin; Prostaglandins E; Pyridoxamine | 2006 |
Low concentrations of reactive gamma-ketoaldehydes prime thromboxane-dependent human platelet aggregation via p38-MAPK activation.
Topics: Blood Platelets; Blotting, Western; Collagen; Cytosol; Humans; Isoprostanes; MAP Kinase Kinase Kinases; Phospholipases A2; Phosphorylation; Platelet Activation; Platelet Aggregation; Prostaglandins E; Proto-Oncogene Proteins; Pyridoxamine; Thromboxane B2; Vitamin B Complex | 2009 |